REFERENCES
1. SEER training modules: physiology of circulation. U.S. National Institutes of Health, National Cancer Institute, 2026. Available from: https://training.seer.cancer.gov [Last accessed on 11 Nov 2026].
2. Shao Y, Cheng Z, Li X, Chernaya V, Wang H, Yang XF. Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction-a novel mechanism for maintaining vascular function. J Hematol Oncol 2014;7:80.
3. Lu Y, Sun Y, Xu K, et al. Aorta in pathologies may function as an immune organ by upregulating secretomes for immune and vascular cell activation, differentiation and trans-differentiation—early secretomes may serve as drivers for trained immunity. Front Immunol 2022;13:858256.
4. Mai J, Virtue A, Shen J, Wang H, Yang X. An evolving new paradigm: endothelial cells - conditional innate immune cells. J Hematol Oncol 2013;6:61.
5. Shao Y, Saredy J, Yang WY, et al. Vascular endothelial cells and innate immunity. Arterioscler Thromb Vasc Biol 2020;40:e138-52.
6. Yang X, Yin Y, Wang H. Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells. Drug Discov Today Ther Strateg 2008;5:125-42.
7. Yang Q, Saaoud F, Lu Y, et al. Innate immunity of vascular smooth muscle cells contributes to two-wave inflammation in atherosclerosis, twin-peak inflammation in aortic aneurysms and trans-differentiation potential into 25 cell types. Front Immunol 2024;14:1348238.
8. Yuan Z, Shu L, Fu J, et al. Single-cell RNA sequencing deconstructs the distribution of immune cells within abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 2024;44:1986-2003.
9. Drummer C, Saaoud F, Shao Y, et al. Trained immunity and reactivity of macrophages and endothelial cells. Arterioscler Thromb Vasc Biol 2021;41:1032-46.
10. Berendam SJ, Koeppel AF, Godfrey NR, et al. Comparative transcriptomic analysis identifies a range of immunologically related functional elaborations of lymph node associated lymphatic and blood endothelial cells. Front Immunol 2019;10:816.
11. Yin Y, Pastrana JL, Li X, et al. Inflammasomes: sensors of metabolic stresses for vascular inflammation. Front Biosci 2013;18:638-49.
12. Yin Y, Yan Y, Jiang X, et al. Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol 2009;22:311-22.
13. Wang X, Li Y, Nanayakkara G, et al. Lysophospholipid receptors, as novel conditional danger receptors and homeostatic receptors modulate inflammation—novel paradigm and therapeutic potential. J Cardiovasc Transl Res 2016;9:343-59.
14. Shao Y, Nanayakkara G, Cheng J, et al. Lysophospholipids and their receptors serve as conditional DAMPs and DAMP receptors in tissue oxidative and inflammatory injury. Antioxid Redox Signal 2018;28:973-86.
15. Shao Y, Saredy J, Xu K, et al. Endothelial immunity trained by coronavirus infections, DAMP stimulations and regulated by anti-oxidant NRF2 may contribute to inflammations, myelopoiesis, COVID-19 cytokine storms and thromboembolism. Front Immunol 2021;12:653110.
16. Saaoud F, Liu L, Xu K, et al. Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress/mitochondrial ROS/glycolysis pathways. JCI Insight 2023;8:e158183.
17. Li X, Wang L, Fang P, et al. Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation. J Biol Chem 2018;293:11033-45.
18. Xu K, Shao Y, Saaoud F, et al. Novel knowledge-based transcriptomic profiling of lipid lysophosphatidylinositol-induced endothelial cell activation. Front Cardiovasc Med 2021;8:773473.
19. Yang WY, Ben Issa M, Saaoud F, et al. Perspective: pathological transdifferentiation—a novel therapeutic target for cardiovascular diseases and chronic inflammation. Front Cardiovasc Med 2024;11:1500775.
20. Xu K, Saaoud F, Yu S, et al. Monocyte adhesion assays for detecting endothelial cell activation in vascular inflammation and atherosclerosis. In: Ramji D, editors. Atherosclerosis. New York, NY: Springer; 2022. pp. 169-82.
21. Yap C, Mieremet A, De Vries CJ, Micha D, De Waard V. Six shades of vascular smooth muscle cells illuminated by KLF4 (Krüppel-like factor 4). Arterioscler Thromb Vasc Biol 2021;41:2693-707.
22. Liu J, Nanayakkara GK, Lu Y, et al. A new paradigm: 46 structural cell types function as environment-supporting innate immune cells, with endothelial and vascular smooth muscle cells as key prototypes. iNew Med 2026;2:e70050.
23. Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, Reinhart TA. Human lymphatic endothelial cells express multiple functional TLRs. J Immunol 2008;180:3399-405.
24. Lucas ED, Tamburini BAJ. Lymph node lymphatic endothelial cell expansion and contraction and the programming of the immune response. Front Immunol 2019;10:36.
25. Tewalt EF, Cohen JN, Rouhani SJ, et al. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood 2012;120:4772-82.
26. Kedl RM, Tamburini BA. Antigen archiving by lymph node stroma: a novel function for the lymphatic endothelium. Eur J Immunol 2015;45:2721-9.
27. Hirosue S, Vokali E, Raghavan VR, et al. Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells. J Immunol 2014;192:5002-11.
29. Pei Y, Lin W, Zhang T, et al. Periaortic lymphatic vessels protect against thoracic aortic dissection through mobilizing immune response. Cardiovasc Res 2025;121:2594-609.
30. Vigl B, Aebischer D, Nitschké M, et al. Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner. Blood 2011;118:205-15.
31. Rouhani SJ, Eccles JD, Riccardi P, et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun 2015;6:6771.
32. Sheridan RM, Doan TA, Lucas CJ, et al. A specific gene expression program underlies antigen archiving by lymphatic endothelial cells in mammalian lymph nodes. Nat Commun 2025;16:8375.
33. Vokali E, Yu SS, Hirosue S, et al. Lymphatic endothelial cells prime naïve CD8+ T cells into memory cells under steady-state conditions. Nat Commun 2020;11:538.
34. Lu Y, Sun Y, Saaoud F, et al. ER stress mediates Angiotensin II-augmented innate immunity memory and facilitates distinct susceptibilities of thoracic from abdominal aorta to aneurysm development. Front Immunol 2023;14:1268916.
35. Davis FM, Tsoi LC, Ma F, et al. Single-cell transcriptomics reveals dynamic role of smooth muscle cells and enrichment of immune cell subsets in human abdominal aortic aneurysms. Ann Surg 2022;276:511-21.
36. Kan H, Zhang K, Mao A, et al. Single-cell transcriptome analysis reveals cellular heterogeneity in the ascending aortas of normal and high-fat diet-fed mice. Exp Mol Med 2021;53:1379-89.
37. Xu J, Liu Z, Yang Q, et al. Adenosine kinase inhibition protects mice from abdominal aortic aneurysm via epigenetic modulation of VSMC inflammation. Cardiovasc Res 2024;120:1202-17.
38. Guo X, Zhong J, Zhao Y, et al. LXRα promotes abdominal aortic aneurysm formation through UHRF1 epigenetic modification of miR-26b-3p. Circulation 2024;150:30-46.
39. Wen Y, Liu Y, Li Q, et al. Spatiotemporal ATF3 expression determines VSMC fate in abdominal aortic aneurysm. Circ Res 2024;134:1495-511.
40. Li Y, Ren P, Dawson A, et al. Single-cell transcriptome analysis reveals dynamic cell populations and differential gene expression patterns in control and aneurysmal human aortic tissue. Circulation 2020;142:1374-88.
41. Wirka RC, Wagh D, Paik DT, et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat Med 2019;25:1280-9.
42. Shao Y, Saaoud F, Cornwell W, et al. Cigarette smoke and morphine promote treg plasticity to Th17 via enhancing trained immunity. Cells 2022;11:2810.
43. Shao Y, Cornwell W, Xu K, et al. Chronic exposure to the combination of cigarette smoke and morphine decreases CD4+ regulatory T cell numbers by reprogramming the treg cell transcriptome. Front Immunol 2022;13:887681.
44. Saaoud F, Shao Y, Cornwell W, Wang H, Rogers TJ, Yang X. Cigarette smoke modulates inflammation and immunity via reactive oxygen species-regulated trained immunity and trained tolerance mechanisms. Antioxid Redox Signal 2023;38:1041-69.
45. Yin Y, Li X, Sha X, et al. Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway. Arterioscler Thromb Vasc Biol 2015;35:804-16.
46. Mai J, Nanayakkara G, Lopez-Pastrana J, et al. Interleukin-17A promotes aortic endothelial cell activation via transcriptionally and post-translationally activating p38 mitogen-activated protein kinase (MAPK) pathway. J Biol Chem 2016;291:4939-54.
47. Virtue A, Johnson C, Lopez-Pastraña J, et al. MicroRNA-155 deficiency leads to decreased atherosclerosis, increased white adipose tissue obesity, and non-alcoholic fatty liver diseasee: a novel mouse model of obesity paradox. J Biol Chem 2017;292:1267-87.
48. Li X, Shao Y, Sha X, et al. IL-35 (interleukin-35) suppresses endothelial cell activation by inhibiting mitochondrial reactive oxygen species-mediated site-specific acetylation of H3K14 (histone 3 lysine 14). Arterioscler Thromb Vasc Biol 2018;38:599-609.
49. Yan Y, Xiong Z, Zhang S, et al. CD25highT cells with a prolonged survival inhibit development of diabetes. Int J Immunopathol Pharmacol 2008;21:767-80.
50. Fang P, Zhang D, Cheng Z, et al. Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis. Diabetes 2014;63:4275-90.
51. Xi H, Zhang Y, Xu Y, et al. Caspase-1 inflammasome activation mediates homocysteine-induced pyrop-apoptosis in endothelial cells. Circ Res 2016;118:1525-39.
52. Zhang D, Fang P, Jiang X, et al. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLR/CBS-deficient mice. Circ Res 2012;111:37-49.
53. Zhang D, Jiang X, Fang P, et al. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine β-synthase-deficient mice. Circulation 2009;120:1893-902.
54. Drummer CIV, Saaoud F, Sun Y, et al. Hyperlipidemia may synergize with hypomethylation in establishing trained immunity and promoting inflammation in NASH and NAFLD. J Immunol Res 2021;2021:1-35.
55. Drummer C, Saaoud F, Jhala NC, et al. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages. Front Immunol 2023;14:1113883.
56. Johnson C, Drummer C, Virtue A, et al. Increased expression of resistin in MicroRNA-155-deficient white adipose tissues may be a possible driver of metabolically healthy obesity transition to classical obesity. Front Physiol 2018;9:1297.
57. Johnson C, Drummer Iv C, Shan H, et al. A novel subset of CD95+ pro-inflammatory macrophages overcome miR155 deficiency and may serve as a switch from metabolically healthy obesity to metabolically unhealthy obesity. Front Immunol 2021;11:619951.
58. Sun Y, Lu Y, Liu L, et al. Caspase-4/11 promotes hyperlipidemia and chronic kidney disease-accelerated vascular inflammation by enhancing trained immunity. JCI Insight 2024;9:e177229.
59. Monroy MA. Chronic kidney disease alters vascular smooth muscle cell phenotype. Front Biosci 2015;20:784-95.
60. Ferrer LM, Monroy AM, Lopez-Pastrana J, et al. Caspase-1 plays a critical role in accelerating chronic kidney disease-promoted neointimal hyperplasia in the carotid artery. J Cardiovasc Transl Res 2016;9:135-44.
61. Li R. Uremic toxins are conditional danger- or homeostasis-associated molecular patterns. Front Biosci 2018;23:348-87.
62. Zhang R, Saredy J, Shao Y, et al. End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression. Redox Biol 2020;34:101460.
63. Lu Y, Sun Y, Saaoud F, et al. Uremic toxin receptor NR1H3 contributes to hyperlipidemia- and chronic kidney disease-accelerated vascular inflammation, which is partially suppressed by novel YBX2 anti-ROS pathway. Redox Biol 2025;85:103724.
64. Cavagnero KJ, Gallo RL. Essential immune functions of fibroblasts in innate host defense. Front Immunol 2022;13:1058862.
65. Dabravolski SA, Andreeva ER, Eremin II, et al. The role of pericytes in regulation of innate and adaptive immunity. Biomedicines 2023;11:600.
66. Mutsaers SE, Pixley FJ, Prêle CM, Hoyne GF. Mesothelial cells regulate immune responses in health and disease: role for immunotherapy in malignant mesothelioma. Curr Opin Immunol 2020;64:88-109.
67. Kim SW, Seok SH. Beyond barriers: when neurons act immune and immunity acts neural. Sig Transduct Target Ther 2025;10:392.
68. Yu D, Jain S, Wangzhou A, et al. Microglia regulate GABAergic neurogenesis in prenatal human brain through IGF1. Nature 2025;646:676-86.
69. Wheeler MA, Quintana FJ. The neuroimmune connectome in health and disease. Nature 2025;638:333-42.
70. Lopez-Pastrana J, Ferrer LM, Li Y, et al. Inhibition of caspase-1 activation in endothelial cells improves angiogenesis: a novel therapeutic potential for ischemia. J Biol Chem 2015;290:17485-94.
71. Li YF, Huang X, Li X, et al. Caspase-1 mediates hyperlipidemia-weakened progenitor cell vessel repair. Front Biosci 2016;21:178-91.
72. Li Y, Nanayakkara G, Sun Y, et al. Analyses of caspase-1-regulated transcriptomes in various tissues lead to identification of novel IL-1β-, IL-18- and sirtuin-1-independent pathways. J Hematol Oncol 2017;10:40.
73. Chen L, Li JY, Nguyen P, et al. Pulsatile flow induces chromatin interaction with lamin-associated proteins to enrich H3K9 methylation in endothelial cells. Proc Natl Acad Sci USA 2025;122:e2424566122.
74. Sriram K, Qi Z, Yuan D, et al. Regulation of nuclear transcription by mitochondrial RNA in endothelial cells. eLife 2024;13:e86204.
75. Senbanerjee S, Lin Z, Atkins GB, et al. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 2004;199:1305-15.
76. Li X, Fang P, Yang WY, et al. Mitochondrial ROS, uncoupled from ATP synthesis, determine endothelial activation for both physiological recruitment of patrolling cells and pathological recruitment of inflammatory cells. Can J Physiol Pharmacol 2017;95:247-52.
77. Nanayakkara GK, Wang H, Yang X. Proton leak regulates mitochondrial reactive oxygen species generation in endothelial cell activation and inflammation - A novel concept. Arch Biochem Biophys 2019;662:68-74.
78. Li X, Fang P, Li Y, et al. Mitochondrial reactive oxygen species mediate lysophosphatidylcholine-induced endothelial cell activation. Arterioscler Thromb Vasc Biol 2016;36:1090-100.
79. Xu K, Saaoud F, Shao Y, et al. Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysis. Redox Biol 2023;64:102771.
80. Saaoud F, Lu Y, Xu K, et al. Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers - targeting PERK as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer. Pharmacol Ther 2024;255:108604.
81. Hawkins BJ, Solt LA, Chowdhury I, et al. G protein-coupled receptor Ca2+-linked mitochondrial reactive oxygen species are essential for endothelial/leukocyte adherence. Mol Cell Biol 2023;27:7582-93.
82. Gao KM, Chiang K, Jiang Z, et al. Endothelial cell expression of a STING gain-of-function mutation initiates pulmonary lymphocytic infiltration. Cell Rep 2024;43:114114.
83. An Y, Geng K, Wang H, et al. Hyperglycemia-induced STING signaling activation leads to aortic endothelial injury in diabetes. Cell Commun Signal 2023;21:365.
84. Xu J, Zheng Y, Zhao Y, et al. Succinate/IL-1β signaling axis promotes the inflammatory progression of endothelial and exacerbates atherosclerosis. Front Immunol 2022;13:817572.
85. Lu Y, Sun Y, Drummer C, et al. Increased acetylation of H3K14 in the genomic regions that encode trained immunity enzymes in lysophosphatidylcholine-activated human aortic endothelial cells - novel qualification markers for chronic disease risk factors and conditional DAMPs. Redox Biol 2019;24:101221.
86. Van Kesteren S, Smeehuijzen L, Stevenson R, Kroon J. Endothelial cells modulate immune cell responses during atherosclerosis. Trends Immunol 2026;47:746-65.
87. Kotlyarov S. Immune function of endothelial cells: evolutionary aspects, molecular biology and role in atherogenesis. Int J Mol Sci 2022;23:9770.
88. Lu Y, Sun Y, Xu K, et al. Editorial: Endothelial cells as innate immune cells. Front Immunol 2022;13:1035497.
89. Shankman LS, Gomez D, Cherepanova OA, et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med 2015;21:628-37.
90. Xu K, Hung SY, Saaoud F, et al. Novel organelle-based intracellular immunity with mechanistic and therapeutic implications. Barrier Immun 2026;2:68-94.
91. Xu K, Saaoud F, Shao Y, et al. A new paradigm in intracellular immunology: mitochondria emerging as leading immune organelles. Redox Biol 2024;76:103331.
92. Byon CH, Javed A, Dai Q, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008;283:15319-27.
93. Chan MM, Yang X, Wang H, Saaoud F, Sun Y, Fong D. The microbial metabolite trimethylamine N-oxide links vascular dysfunctions and the autoimmune disease rheumatoid arthritis. Nutrients 2019;11:1821.
94. Saaoud F, Martinez L, Lu Y, et al. Chronic kidney disease transdifferentiates veins into a specialized immune-endocrine organ with increased MYCN-AP1 signaling. Cells 2023;12:1482.
95. Martinez L, Stoyell-Conti FF, Tabbara M, et al. The single-cell landscape of the human vein after arteriovenous fistula creation and implications for maturation failure. Kidney Int 2026;109:160-77.
96. Peluzzo AM, Bkhache M, Do LNH, Autieri MV, Liu X. Differential regulation of lymphatic junctional morphology and the potential effects on cardiovascular diseases. Front Physiol 2023;14:1198052.
97. Liu X, Oliver G. The lymphatic vasculature in cardiac development and ischemic heart disease. Circ Res 2023;132:1246-53.
98. Liu X, Cui K, Wu H, et al. Promoting lymphangiogenesis and lymphatic growth and remodeling to treat cardiovascular and metabolic diseases. Arterioscler Thromb Vasc Biol 2023;43:e1-10.
99. Shen Q, Gu G, Yang D, Zheng Y. Dysfunction and pathological origins of lymphatic endothelial cells in atherosclerosis revealed by single-cell transcriptomics. Genes 2025;16:1398.
100. Jalkanen S, Salmi M. Lymphatic endothelial cells of the lymph node. Nat Rev Immunol 2020;20:566-78.
101. Den Braanker H, Van Stigt A, Kok M, Lubberts E, Bisoendial R. Single-cell RNA sequencing reveals heterogeneity and functional diversity of lymphatic endothelial cells. Int J Mol Sci 2021;22:11976.
102. Takeda A, Hollmén M, Dermadi D, et al. Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils. Immunity 2019;51:561-72.e5.
103. Rivers AK, Migues Ramirez C, Cleary SJ. Lymphatic endothelial cells actively shape immune responses in the lungs. Curr Opin Immunol 2026;101:102802.
104. Card CM, Yu SS, Swartz MA. Emerging roles of lymphatic endothelium in regulating adaptive immunity. J Clin Investig 2014;124:943-52.
105. Chen W, Wang Y, Zhang D, Zhang Y, Qin X, Wang X. The crosstalk between lymphatic endothelial cells and immune cells in Physiological and Pathological conditions. Cell Mol Life Sci 2026;83:309.
106. Takeda A, Salmi M, Jalkanen S. Lymph node lymphatic endothelial cells as multifaceted gatekeepers in the immune system. Trends Immunol 2023;44:72-86.
107. Cohen JN, Guidi CJ, Tewalt EF, et al. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med 2010;207:681-8.
108. Shao Y, Yang WY, Nanayakkara G, et al. Immune checkpoints are new therapeutic targets in regulating cardio-, and cerebro-vascular diseases and CD4+Foxp3+ regulatory T cell immunosuppression. Int J Drug Discov Pharm 2024;3:100022.
109. Shao Y, Saaoud F, Xu K, et al. A comprehensive analysis of immune checkpoint receptor-ligand pairs in aortic diseases highlights the immunosuppressive roles of CD155 and CD274. Genes Dis 2025;13:101724.
110. Shen H, Wu N, Nanayakkara G, et al. Co-signaling receptors regulate T-cell plasticity and immune tolerance. Front Biosci 2019;24:96-132.
111. Han B, Xu K, Saaoud F, et al. Discovery of seven ROS-sensitive immune checkpoints and 46 ligands mediating immune suppression through T cell-APC networks. J Cancer 2026;17:439-56.
112. Piao W, Xiong Y, Li L, et al. Regulatory T cells condition lymphatic endothelia for enhanced transendothelial migration. Cell Rep 2020;30:1052-62.e5.
113. Liu X, Yang X, Autieri MV. Editorial: Exploring lymphatic vasculature's role in cardiovascular and metabolic diseases. Front Cardiovasc Med 2026;13:1805707.
114. Henri O, Pouehe C, Houssari M, et al. Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction. Circulation 2016;133:1484-97.
115. Vieira JM, Norman S, Villa Del Campo C, et al. The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction. J Clin Investig 2018;128:3402-12.
116. Liu X, De La Cruz E, Gu X, et al. Lymphoangiocrine signals promote cardiac growth and repair. Nature 2020;588:705-11.
117. Wang W, Li X, Ding X, et al. Lymphatic endothelial transcription factor Tbx1 promotes an immunosuppressive microenvironment to facilitate post-myocardial infarction repair. Immunity 2023;56:2342-57.e10.
118. Keller TS, Lim L, Shewale SV, et al. Genetic blockade of lymphangiogenesis does not impair cardiac function after myocardial infarction. J Clin Investig 2021;131:e147070.
119. Peluzzo AM, St. Paul A, Corbett CB, et al. IL-19 is a novel lymphangiocrine factor inducing lymphangiogenesis and lymphatic junctional regulation. Arterioscler Thromb Vasc Biol 2025;45:1244-65.
